Dr. Amrie Grammer, co-founder, president and chief scientific officer of AMPEL BioSolutions, joins hosts Holly Buckley and Kristen McDermott Woodrum on this episode of Health+Tech. They discuss AMPEL’s mission to bring personalized precision medicine to patients and the technology behind that medicine.
Grammer explains how AMPEL built and leveraged its genomic platform to create personalized precision medicine for patients with autoimmune and inflammatory diseases. Also on this episode of Health+Tech, Grammer announces the development of AMPEL’s mobile app, facilitating optimal communication between patients and providers.
